Glenmark Pharma approves Ryaltris in Australia
Ryaltris is a new fixed‐dose combination nasal spray of an antihistamine and a steroid indicated for treatment of symptoms…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenn Saldanha
Glenmark records a 29.89 per cent growth in Q4 FY 15-16
India Business grew at 22.52 per cent to Rs 5,397.72 million for the quarter and to Rs 21,092.72 million for the year
Union Budget 2016-17: Glenn Saldanha, Chairman and MD– Glenmark Pharmaceuticals
The budget did not announce anything specific for the pharma sector
Glenmark’s novel monoclonal antibody GBR 830 to enter phase II clinical studies
GBR 830 targets activated T cells, which drives the pathology in most autoimmune diseases including rheumatoid arthritis, multiple…
Glenmark’s consolidated revenue increases by 11.32 per cent to Rs 16,552.48 million in Q1 FY 15-16
Consolidated net profit for Q1 FY 15-16 was Rs 1909.38 million
Glenmark Pharmaceuticals announced its results for the first…
Glenmark’s consolidated revenue increases by 10.62 per cent to Rs 66447.68 million in FY 14-15
Consolidated revenue in Q4 FY14-15 was Rs 17758.13 million an increase of 4.24 per cent
Glenmark Pharmaceuticals announced its…
SAC-ACCP organises eighth annual international conference
Felicitates six industry stakeholders and institutions
South Asian Chapter of American College of Clinical Pharmacology…